Logo image of SONX

SONENDO INC (SONX) Stock Fundamental Analysis

NYSE:SONX - New York Stock Exchange, Inc. - US8354311073 - Common Stock - Currency: USD

0.23  -0.01 (-4.33%)

Fundamental Rating

2

Taking everything into account, SONX scores 2 out of 10 in our fundamental rating. SONX was compared to 187 industry peers in the Health Care Equipment & Supplies industry. SONX may be in some trouble as it scores bad on both profitability and health. SONX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SONX has reported negative net income.
SONX had a negative operating cash flow in the past year.
SONX Yearly Net Income VS EBIT VS OCF VS FCFSONX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -68.96%, SONX is not doing good in the industry: 77.83% of the companies in the same industry are doing better.
The Return On Equity of SONX (-161.08%) is worse than 76.35% of its industry peers.
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROIC N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SONX Yearly ROA, ROE, ROICSONX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150

1.3 Margins

With a Gross Margin value of 26.06%, SONX is not doing good in the industry: 75.37% of the companies in the same industry are doing better.
SONX's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for SONX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
SONX Yearly Profit, Operating, Gross MarginsSONX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -50 -100 -150

More info and screens

3

2. Health

2.1 Basic Checks

SONX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SONX has more shares outstanding
The debt/assets ratio for SONX is higher compared to a year ago.
SONX Yearly Shares OutstandingSONX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M
SONX Yearly Total Debt VS Total AssetsSONX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -7.33, we must say that SONX is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -7.33, SONX is not doing good in the industry: 73.89% of the companies in the same industry are doing better.
SONX has a Debt/Equity ratio of 0.98. This is a neutral value indicating SONX is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.98, SONX is doing worse than 78.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z -7.33
ROIC/WACCN/A
WACC11.71%
SONX Yearly LT Debt VS Equity VS FCFSONX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M

2.3 Liquidity

SONX has a Current Ratio of 6.80. This indicates that SONX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 6.80, SONX is in the better half of the industry, outperforming 79.80% of the companies in the same industry.
A Quick Ratio of 5.77 indicates that SONX has no problem at all paying its short term obligations.
SONX has a better Quick ratio (5.77) than 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 5.77
SONX Yearly Current Assets VS Current LiabilitesSONX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

5

3. Growth

3.1 Past

SONX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 72.34%, which is quite impressive.
The Revenue has grown by 12.92% in the past year. This is quite good.
Measured over the past years, SONX shows a small growth in Revenue. The Revenue has been growing by 6.25% on average per year.
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%

3.2 Future

SONX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.40% yearly.
SONX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 18.20% yearly.
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SONX Yearly Revenue VS EstimatesSONX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SONX Yearly EPS VS EstimatesSONX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -1 -2 -3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SONX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SONX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SONX Price Earnings VS Forward Price EarningsSONX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SONX Per share dataSONX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

SONX's earnings are expected to grow with 21.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.85%
EPS Next 3Y21.4%

More info and screens

0

5. Dividend

5.1 Amount

SONX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SONENDO INC

NYSE:SONX (11/21/2023, 8:04:01 PM)

0.23

-0.01 (-4.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-08 2023-11-08/amc
Earnings (Next)03-09 2024-03-09/amc
Inst Owners11.63%
Inst Owner Change0%
Ins Owners24.26%
Ins Owner Change0%
Market Cap12.48M
Analysts80
Price Target1.75 (660.87%)
Short Float %0%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-13.05%
Min EPS beat(2)-26.29%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-1.71%
Min EPS beat(4)-26.29%
Max EPS beat(4)23.85%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.82%
Max Revenue beat(2)-1.48%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-3.82%
Max Revenue beat(4)1.03%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-36.28%
PT rev (3m)-37.73%
EPS NQ rev (1m)-1.82%
EPS NQ rev (3m)-1.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.83%
Revenue NQ rev (1m)-4.58%
Revenue NQ rev (3m)-4.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.33
P/tB 0.44
EV/EBITDA N/A
EPS(TTM)-0.65
EYN/A
EPS(NY)-0.52
Fwd EYN/A
FCF(TTM)-0.96
FCFYN/A
OCF(TTM)-0.94
OCFYN/A
SpS0.82
BVpS0.7
TBVpS0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -68.96%
ROE -161.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.06%
FCFM N/A
ROA(3y)-48.29%
ROA(5y)N/A
ROE(3y)-102.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.24%
GM growth 5YN/A
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.8%
Cap/Sales 2.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.8
Quick Ratio 5.77
Altman-Z -7.33
F-Score4
WACC11.71%
ROIC/WACCN/A
Cap/Depr(3y)67.61%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.38%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70.21%
EPS Next Y65.53%
EPS Next 2Y30.85%
EPS Next 3Y21.4%
EPS Next 5YN/A
Revenue 1Y (TTM)12.92%
Revenue growth 3Y6.25%
Revenue growth 5YN/A
Sales Q2Q%5.69%
Revenue Next Year8.44%
Revenue Next 2Y14.38%
Revenue Next 3Y18.2%
Revenue Next 5YN/A
EBIT growth 1Y-3.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.36%
EBIT Next 3Y15.86%
EBIT Next 5YN/A
FCF growth 1Y-23.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-25.63%
OCF growth 3YN/A
OCF growth 5YN/A